Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Apotea

56.50 SEK

-3.42 %

Less than 1K followers

APOTEA

NASDAQ Stockholm

Personal Goods

Consumer Goods & Services

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-3.42 %
-7.01 %
-38.73 %
-36.08 %
-42.88 %
-32.42 %
-
-
-32.74 %

Apotea operates in the e-commerce sector and operates an online pharmacy. The company sells and delivers a wide range of prescription and non-prescription medicines, skin and hair care products, as well as makeup and various beauty-related products. The company operates in the Swedish domestic market, where the customer base mainly consists of private individuals. Apotea was founded in 2003 and is headquartered in Stockholm.

Read more
Market cap
5.95B SEK
Turnover
49.28M SEK
Revenue
7.2B
EBIT %
4.14 %
P/E
25.68
Dividend yield-%
1.06 %
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
29/4
2026

Interim report Q1'26

26/5
2026

General meeting '26

27/5
2026

Annual dividend

All
Webcasts
Press releases
ShowingAll content types
Apotea, Webcast, Q4'25
Webcast2/4/2026, 8:30 AM

Apotea, Webcast, Q4'25

Apotea
Regulatory press release2/4/2026, 6:30 AM

Apotea AB (publ) bokslutskommuniké 2025: Svag lönsamhet i det fjärde kvartalet

Apotea
Regulatory press release2/4/2026, 6:30 AM

Apotea AB (publ) Year-end report 2025: Weak profitability in the fourth quarter

Apotea

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2/3/2026, 9:55 AM

Finansinspektionen: Flaggningsmeddelande i Apotea AB (publ)

Apotea
Regulatory press release1/28/2026, 1:39 PM

Apotea rekryterar Joanna Hummel för att accelerera bolagets tillväxtinitiativ

Apotea
Regulatory press release1/28/2026, 1:39 PM

Apotea has recruited Joanna Hummel to accelerate the company’s growth initiatives

Apotea
Regulatory press release1/20/2026, 5:16 PM

Uppdatering avseende det fjärde kvartalet 2025

Apotea
Regulatory press release1/20/2026, 5:16 PM

Update regarding the fourth quarter of 2025

Apotea
Press release12/18/2025, 10:30 AM

Inbjudan till Apoteas presentation av bokslutskommunikén för 2025

Apotea
Press release12/18/2025, 10:30 AM

Invitation to Apotea’s presentation of the year-end report 2025

Apotea
Regulatory press release12/8/2025, 10:45 AM

Finansinspektionen: Flaggningsmeddelande i Apotea AB (publ)

Apotea
Apotea, Webcast, Q3'25
Webcast11/6/2025, 8:30 AM

Apotea, Webcast, Q3'25

Apotea
Regulatory press release11/6/2025, 6:30 AM

Apotea AB (publ) delårsrapport Q3 2025: Framgångsrik produktionsstart i Varberg och fortsatt god lönsamhet

Apotea
Regulatory press release11/6/2025, 6:30 AM

Apotea AB (publ) Interim report Q3 2025: Successful production launch in Varberg and continued good profitability

Apotea
Press release10/3/2025, 8:00 AM

Inbjudan till Apoteas webcast för det tredje kvartalet 2025

Apotea
Press release10/3/2025, 8:00 AM

Invitation to Apotea’s Q3 2025 webcast

Apotea
Regulatory press release8/22/2025, 6:55 AM

Apotea: Arbetstagarrepresentanter i styrelsen

Apotea
Regulatory press release8/22/2025, 6:55 AM

Apotea: Employee representatives on the Board of Directors

Apotea
Regulatory press release8/8/2025, 7:08 AM

Finansinspektionen: Flaggningsmeddelande i Apotea AB (publ)

Apotea
Regulatory press release8/6/2025, 6:57 AM

Finansinspektionen: Flaggningsmeddelande i Apotea AB (publ)

Apotea
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.